02.10.2024, 13:33

Kazakhstan's antitrust authorities conclude investigation into Damumed for unfair pricing

ASTANA. Oct 2 (Interfax-Kazakhstan) - Kazakhstan's antitrust authorities have concluded the investigation into the operator of the Damumed medical database for overpriced services from 2020 to 2022.

To read the full news articles, Subscribe.

07:03PM
Bank RBK denies reports about purchase of its shares by ForteBank

06:51PM
Kazakhstan considering possible repatriation flights from Iran, Lebanon, Israel - Foreign Ministry

06:50PM
Kazakhstan will issue Eurobonds on international markets

06:32PM
CIS Council of Foreign Ministers to meet in Moscow on Oct 7

06:08PM
Kazakhstan concerned about escalation in Middle East

04:37PM
AVERAGE WEIGHTED RATE ON OCTOBER 2, 2024 IS 483.23 TENGE FOR $1

03:26PM
Unresolved issues in creating common energy market slowing EAEU economies - Pashinyan

03:25PM
EAEU, UAE might finalize free trade agreements at BRICS summit in Oct - Eurasian Economic Commission

03:24PM
Share of settlements in national currencies within EAEU reaches 90% - Eurasian Economic Commission board chair

03:22PM
Kyrgyz PM: Digital transformation serves as basis for EAEU development

01:39PM
Russian peacekeepers repel mock enemy attack during Kazakhstan exercises

01:35PM
IMF raises economic growth forecast for Uzbekistan to over 5.5%/year in 2024-2025

01:09PM
EAEU countries approve concept for commodities exchange market without oil products

12:37PM
Suspects detained in Zhetysu Region for firearms trafficking, including stolen weapons from 2022 unrest

Press center

https://press.interfax.kz

YE’S INTERNATIONAL HOTEL COMPANY EXITS MANAGEMENT OF YE’S ASTANA APARTHOTEL IN KAZAKHSTAN

KASE IS FOCUSED ON INCREASING THE FINANCING OF SMALL AND MEDIUM-SIZED ENTERPRISES

ADB EXPERTS ARE READY TO SUPPORT THE GOVERNMENT IN TAX REFORMS

THE UNITED KINGDOM MAY PROVIDE £4 BILLION TO FINANCE KAZAKHSTAN-BASED PROJECTS THAT SHOULD INCLUDE UK CONTENT

Kazakhstan's antitrust authorities conclude investigation into Damumed for unfair pricing

Press center